loperamide has been researched along with rifamycins in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, JA; Belkind-Gerson, J; De La Cabada, FJ; Dupont, HL; Dupont, MW; Ericsson, CD; Huang, DB; Jaini, S; Jiang, ZD; Ke, S; Martinez Sandoval, F; Okhuysen, PC; Taylor, DN | 1 |
| Andresen, V; Layer, P | 1 |
| Berumen, J; Bonham, CA; Concepcion, W; Esquivel, C; Feinberg, E; Todo, T | 1 |
| Lembo, AJ; Nee, J; Zakari, M | 1 |
| Morgan, B | 1 |
| Talley, NJ | 1 |
2 review(s) available for loperamide and rifamycins
| Article | Year |
|---|---|
Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea.
Topics: Administration, Oral; Anti-Infective Agents; Antidiarrheals; Ciprofloxacin; Diarrhea; Humans; Loperamide; Rifamycins; Rifaximin; Travel; Treatment Outcome | 2010 |
Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome.
Topics: Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Loperamide; Phenylalanine; Receptors, Opioid; Rifamycins; Rifaximin | 2015 |
1 trial(s) available for loperamide and rifamycins
| Article | Year |
|---|---|
Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
Topics: Adolescent; Adult; Anti-Infective Agents; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Loperamide; Male; Probability; Reference Values; Rifamycins; Rifaximin; Risk Assessment; Travel; Treatment Outcome | 2007 |
3 other study(ies) available for loperamide and rifamycins
| Article | Year |
|---|---|
Complications following liver transplantation for progressive familial intrahepatic cholestasis.
Topics: Anastomosis, Roux-en-Y; Animals; Anti-Bacterial Agents; Biliary Tract; Biliary Tract Surgical Procedures; Child; Cholangitis; Cholestasis, Intrahepatic; Fatty Liver; Female; Graft Rejection; Humans; Jejunostomy; Jejunum; Liver Transplantation; Loperamide; Rifamycins; Rifaximin; Steroids | 2014 |
Drug development: A healthy pipeline.
Topics: Animals; Benzimidazoles; Benzofurans; Bile Acids and Salts; Carbolines; Colesevelam Hydrochloride; Colestipol; Disease Models, Animal; Enteric Nervous System; Female; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Loperamide; Lubiprostone; Male; Mice; Natriuretic Peptides; Peptides; Phenylalanine; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Rifamycins; Rifaximin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Visceral Pain | 2016 |
Board Review Vignette: Irritable Bowel Syndrome.
Topics: Abdominal Pain; Adult; Anion Exchange Resins; Antidiarrheals; Carbolines; Cholestyramine Resin; Constipation; Diarrhea; Disease Management; Female; Gastrointestinal Agents; Guanylyl Cyclase C Agonists; Humans; Imidazoles; Irritable Bowel Syndrome; Laxatives; Loperamide; Peptides; Phenylalanine; Probiotics; Rifamycins; Rifaximin; Selective Serotonin Reuptake Inhibitors | 2016 |